CNBC February 27, 2018
Dr. John Noseworthy, president and CEO of The Mayo Clinic

  • There are a number of opportunities for biotech innovation and health system improvement in biotherapeutics, molecular imaging, genomics and software development.
  • Like Aetna and CVS, it is the unconventional alliances that will create new health-care solutions that will change the world.
  • John Noseworthy is an advisory board member for Healthy Returns, CNBC’s new health-care innovation conference, on March 28, 2018, in New York City.

In 2010, Rock Health was stationed in an old Chinese restaurant in San Francisco. When we made our first exploratory visit there to seek fresh insight about digital innovation and medical technology, the building still smelled faintly of ginger.

Our team from Mayo Clinic — the 150-year-old health-care organization that invented the first group...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Health IT, Healthcare System, Mergers & Acquisitions / JV, Precision Medicine
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article